RESMED INC. DL-,004/ US7611521078 /
2024-10-04 9:20:23 PM | Chg. -1.60 | Volume | Bid9:31:00 PM | Ask9:31:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
213.40EUR | -0.74% | 116 Turnover: 24,957.60 |
213.90Bid Size: 240 | 214.60Ask Size: 240 | 31.38 bill.EUR | - | - |
GlobeNewswire
08-28
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
08-15
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader ...
GlobeNewswire
07-25
NATIONAL CENTER ON SHAKEN BABY SYNDROME AND XEALTH INCREASE SPEED AND ACCESSIBILITY OF CRITICAL PARE...
GlobeNewswire
06-27
XEALTH LAUNCHES DEWEY, THE INDUSTRY’S FIRST PERFORMANCE-BASED, DIGITAL HEALTH BENCHMARKING TOOL
GlobeNewswire
06-10
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
05-23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
05-16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
05-16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
05-07
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS